Return on Equity (ROE)
Updated 126h ago
Sector Performance
54th percentileDOV
15.0%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how much profit a company generates for each dollar of shareholders’ money; a 15.0% ROE means DOV earns $0.15 of profit per dollar of equity.
That figure sits above the sector median of 13.8%, placing DOV in the 55th percentile among its peers—meaning it outperforms slightly more than half of them. Trend data are not available: the year-over-year change and quarter-over-quarter change are both reported as N/A, so no directional insight can be drawn from recent performance. The combination of a ROE that is above the sector median but with no trend information implies a moderate earnings efficiency that lacks a clear trajectory, offering neither a strong risk nor a clear opportunity. This metric supports the overall NEUTRAL verdict—the ROE is solid relative to peers but not exceptional, and the absence of trend keeps the assessment balanced.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about DOV?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are DOV's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master DOV's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full DOV research report →DOV
15.0%
Sector Median
13.8%
Sector Avg
31.4%
How DOV's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.